44 PRIMECAP Management Boston Scientific Trades
PRIMECAP Management's position in Boston Scientific is currently worth $2.76 Billion. That's 2.05% of their equity portfolio (12th largest holding). The investor owns 2.60% of the outstanding Boston Scientific stock. The first Boston Scientific trade was made in Q1 2013. Since then PRIMECAP Management bought shares thirteen more times and sold shares on 30 occasions. The stake costed the investor $395 Million, netting the investor a gain of 599% so far.
News about Boston Scientific Corp. and PRIMECAP Management
Mount Lucas Management LP Invests $2.64 Million in Boston Scientific Co. (NYSE:BSX)
… the SEC. The institutional investor bought 48,868 shares of … hedge funds and other institutional investors . Wall Street Analysts Forecast … on the stock....
Diamond Hill Capital Management Inc. Decreases Stock Position in Boston Scientific Co. (NYSE:BSX)
Diamond Hill Capital Management Inc. decreased its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 2.8% in the second quarter, accord...
Baldwin Investment Management LLC Buys New Holdings in Boston Scientific Co. (NYSE:BSX)
Baldwin Investment Management LLC purchased a … $223,000. Other institutional investors and hedge funds also recently … about $32,000. Institutional investor...
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do. However, some of the most significant gains over...